Moderna on X: "In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273. Read more: https://t.co/CPnxL03nZW https://t.co/ODihw6qtsQ" /
Volunteers needed for expanded COVID-19 booster trial | KPWHRI
Funding for immunocompromised COVID-19 booster trial | UNSW Newsroom
Merah Putih Vaccine phase 3 trial conducted alongside booster trial - ANTARA News
Trial confirms safety of mix-and-match COVID-19 vaccine booster | KPWHRI
Vaccine trial to investigate a booster for teenagers to protect against COVID-19 | Health Care Research Wales
Moderna COVID-19 booster clinical trial starting at UMass Chan
Booster trial aims to improve immunity in vulnerable people – UKRI
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
Washington University participates in clinical trial of Moderna omicron booster – Washington University School of Medicine in St. Louis
Baylor launches clinical trial for COVID-19 vaccine booster | BCM
Intravacc launches phase 1 trial for intranasal COVID-19 booster vaccine
Major COVID-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people | NIHR
Skin Hydrating Booster Trial - Bio Aesthetic
BioNTech SE on X: "95.6% relative vaccine efficacy against #Covid19 after a booster shot with our #mRNA vaccine, during a period when Delta was the prevalent strain. These are the first efficacy
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
Studying COVID-19 booster vaccines | Fall 2021 | UC Davis Health Magazine
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
UK launches extensive trial of third booster shots of Covid vaccines
News - Major Covid-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people - University of Nottingham
New global vaccine trial launched to evaluate fractional COVID-19 booster shots - Murdoch Children's Research Institute
Pfizer, BioNTech find updated COVID booster protects against Omicron in trial | Reuters
